MYH6 and dilated cardiomyopathy: One explanation might be that this was a parallel change to adapt to the changes associated with dilated cardiomyopathy and other pathological phenotypes seen in MYH6-Cre-BDNF–/– hearts, which require more gene activation to compensate for the ablation of BDNF in cardiomyocytes.